BeyondSpring, Inc. (BYSI) Q4 2021 Earnings Call Transcript
Joining us on today's call is Dr. Lan Huang, Beyond Spring's co-founder, chairman, and chief executive officer; Dr. Ramon Mohanlal, executive vice president, research and development, and chief medical officer; and Elizabeth Czerepak, chief financial officer. After the company response letter from the U.S. FDA last November, we took steps to streamline our operations in order to extend the cash runway. First, we are pleased with our ongoing discussions with China NMPA under review of plinabulin's NDA in combination with G-CSF for the prevention of chemotherapy-induced neutropenia, or CIN.